Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News CalciMedica Inc CALC

Healthcare
CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CALC)

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis

PR Newswire 9 days ago

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates

PR Newswire March 28, 2024

CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

PR Newswire March 13, 2024

CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

PR Newswire February 28, 2024

CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora(TM) for the Treatment of Severe Acute Kidney Injury

PR Newswire February 13, 2024

CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

PR Newswire February 7, 2024

CalciMedica Announces Private Placement of up to Approximately $55 Million

PR Newswire January 22, 2024

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

PR Newswire November 9, 2023

CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition

PR Newswire November 2, 2023
View More News ››

Opinion & Analysis (NDAQ:CALC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CALC)

RE:GRAY...Symbol & Name Chg...did u expect anything different

phone* Forgot to post the NR........ Graybug Announces Name and Trading Symbol Change 2023-03-20 10:22 ET - News Release REDWOOD...
Iseneschal - March 20, 2023

GRAY...Symbol & Name Chg...did u expect anything different

And that's Post RS ; ) And guess what...... the system is so slanted u won't be able to trade your position unless u phine your...
Iseneschal - March 20, 2023

GRAY..... 14 : 1 Reverse Split eff Today

1.5 million shares o/s now with merger in place Watch for P.O It's not a Level playing field
Iseneschal - March 20, 2023

Graycliff Exploration CEO Update: WATCH AND READ

...
yukon_gold - March 9, 2023

Graycliff Exploration Expands Property Package With Lunge

...
yukon_gold - March 2, 2023

Graycliff Completes Phase 4 Drilling at Shakespeare

  Graycliff Exploration Completes...
yukon_gold - February 22, 2023
View more Bullboard ››

Forge Resources Corp.

Forge Resources Corp.

Forge Resources Corp. is a junior exploration company. The Company is engaged in the business of the exploration and ...
View More »